Singapore markets closed
Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,147.81 +3.68 (+0.05%) Bitcoin USD
57,557.85 -3,983.68 (-6.47%) CMC Crypto 200
1,242.68 -96.38 (-7.20%)
Samsung Biologics Co.,Ltd. (207940.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
Currency in KRW
Valuation measures4
| Market cap (intra-day) | 55.59T |
| Enterprise value | 55.44T |
| Trailing P/E | 64.81 |
| Forward P/E | 65.36 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.05 |
| Price/book (mrq) | 5.65 |
| Enterprise value/revenue | 15.01 |
| Enterprise value/EBITDA | 32.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.51 |
| 52-week change 3 | 0.77% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 880,000.00 |
| 52-week low 3 | 668,000.00 |
| 50-day moving average 3 | 810,800.00 |
| 200-day moving average 3 | 761,470.00 |
Share statistics
| Avg vol (3-month) 3 | 65.54k |
| Avg vol (10-day) 3 | 57.39k |
| Shares outstanding 5 | 71.17M |
| Implied shares outstanding 6 | 72.1M |
| Float 8 | 17.91M |
| % held by insiders 1 | 74.75% |
| % held by institutions 1 | 14.16% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 23.22% |
| Operating margin (ttm) | 32.60% |
Management effectiveness
| Return on assets (ttm) | 4.27% |
| Return on equity (ttm) | 9.12% |
Income statement
| Revenue (ttm) | 3.69T |
| Revenue per share (ttm) | 51,909.25 |
| Quarterly revenue growth (yoy) | 11.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.6T |
| Net income avi to common (ttm) | 857.69B |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | -21.40% |
Balance sheet
| Total cash (mrq) | 2.06T |
| Total cash per share (mrq) | 28,890.83 |
| Total debt (mrq) | 1.91T |
| Total debt/equity (mrq) | 19.42% |
| Current ratio (mrq) | 1.33 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 1.67T |
| Levered free cash flow (ttm) | -446.65B |
© 2024 Yahoo. All rights reserved.